Media

  • Email
  • Help

Information for you

On this page, we highlight information of partcular relevance for media, including news, events and featured information for journalists with a professional interest in the development and availability of medicines in the European Union.

For more information and details relevant for media, see our News & events section. 

For enquiries from media, please contact the EMA press office

Featured information

News for media

Events of interest

  • 06/02/2018

    EMA

    Extraordinary Management Board meeting: 6 February 2018

    The Management Board is an integral governance body of the Agency. It has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director and the monitoring of the Agency’s performance. ... Read more

  • 20/03/2018

    PDCO

    Multi-stakeholder workshop to further improve the implementation of the Paediatric Regulation

    This workshop, organised by the European Medicines Agency (EMA) and the European Commission, follows the publication of the Commission’s ten-year report on implementation of the Paediatric Regulation and the state of paediatric medicines in the European Union. The aim is to discuss potential improvements of the implementation of the Regulation. It will explore opportunities regarding paediatric needs, timely completion of paediatric investigation plans (PIP), and processes and expectations for handling PIP applications. This workshop is a crucial step for the development of a concrete action plan to address challenges identified with medicine development for children in Europe. Invited stakeholders include patients, academia, healthcare professionals and industry. The deadline for expressions of interest is 14 February. EMA will select industry stakeholders via registered associations. The Agency will contact all selected participants on 1 March. ... Read more

  • 25/10/2017

    EMA

    European network of paediatric research at the European Medicines Agency (Enpr-EMA) Coordinating Group and networks meeting

    European network of paediatric research at the European Medicines Agency (Enpr-EMA) Coordinating Group (CG) in 2017 welcomed members of the working groups and representatives of the registered networks. The focus of this meeting was on updates from the working groups on their work since the last update during the face to face 22017 annual workshop of the European network of paediatric research at the European Medicines Agency. The CG also reviewed proposals for the pam-European IMI2 paediatric network and contributions to the public consultation on the reflection pager on the use of extrapolation of efficacy and safety in medicine development. ... Read more

  • 22/11/2017

    EMA

    European network of paediatric research at the European Medicines Agency (Enpr-EMA) Coordinating Group and networks meeting

    The last meeting of the European network of paediatric research at the European Medicines Agency (Enpr-EMA) Coordinating Group in 2017 saw the review of the mandate of the working groups, the endorsement to new network members. The group also discussed the agenda of the 2018 face to face meeting. ... Read more

  • 15/12/2017

    EMA

    Fourteenth joint European Medicines Agency/European network for Health Technology Assessment dialogue meeting

    The EMA and EUnetHTA have been holding regular dialogue since 2010. The key topics of this meeting are concepts related to orphan medicines (significant benefit vs relative effectiveness), opportunities for collaboration on horizon scanning, reflections on the concept of evidence transfer / extrapolation, principles of the working of the indication as well as ongoing initiatives on post-licensing evidence generation. A report from the meeting will be published later. ... Read more

  • See all Events of interest

Information for:

Find information for...